127 related articles for article (PubMed ID: 32151648)
1. Dose-dependent and long-term cerebroprotective effects of intranasal delivery of progesterone after ischemic stroke in male mice.
Fréchou M; Zhu X; Liere P; Pianos A; Schumacher M; Mattern C; Guennoun R
Neuropharmacology; 2020 Jun; 170():108038. PubMed ID: 32151648
[TBL] [Abstract][Full Text] [Related]
2. Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection.
Fréchou M; Zhang S; Liere P; Delespierre B; Soyed N; Pianos A; Schumacher M; Mattern C; Guennoun R
Neuropharmacology; 2015 Oct; 97():394-403. PubMed ID: 26079443
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in the cerebroprotection by Nestorone intranasal delivery following stroke in mice.
Fréchou M; Zhu X; Kumar N; Sitruk-Ware R; Schumacher M; Mattern C; Guennoun R
Neuropharmacology; 2021 Oct; 198():108760. PubMed ID: 34437904
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Dexamethasone Reduces Mortality and Brain Damage in a Mouse Experimental Ischemic Stroke Model.
Espinosa A; Meneses G; Chavarría A; Mancilla R; Pedraza-Chaverri J; Fleury A; Bárcena B; Pérez-Osorio IN; Besedovsky H; Arauz A; Fragoso G; Sciutto E
Neurotherapeutics; 2020 Oct; 17(4):1907-1918. PubMed ID: 32632775
[TBL] [Abstract][Full Text] [Related]
5. Intranasal Delivery of Exendin-4 Confers Neuroprotective Effect Against Cerebral Ischemia in Mice.
Zhang H; Meng J; Zhou S; Liu Y; Qu D; Wang L; Li X; Wang N; Luo X; Ma X
AAPS J; 2016 Mar; 18(2):385-94. PubMed ID: 26689204
[TBL] [Abstract][Full Text] [Related]
6. Intranasal administration of progesterone: A potential efficient route of delivery for cerebroprotection after acute brain injuries.
Guennoun R; Fréchou M; Gaignard P; Liere P; Slama A; Schumacher M; Denier C; Mattern C
Neuropharmacology; 2019 Feb; 145(Pt B):283-291. PubMed ID: 29885423
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice.
Chen D; Lee J; Gu X; Wei L; Yu SP
ASN Neuro; 2015; 7(5):. PubMed ID: 26391329
[TBL] [Abstract][Full Text] [Related]
8. A Role of Endogenous Progesterone in Stroke Cerebroprotection Revealed by the Neural-Specific Deletion of Its Intracellular Receptors.
Zhu X; Fréchou M; Liere P; Zhang S; Pianos A; Fernandez N; Denier C; Mattern C; Schumacher M; Guennoun R
J Neurosci; 2017 Nov; 37(45):10998-11020. PubMed ID: 28986464
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the translational potential of progesterone treatment following transient cerebral ischaemia in male mice.
Wong R; Gibson CL; Kendall DA; Bath PM
BMC Neurosci; 2014 Nov; 15():131. PubMed ID: 25471043
[TBL] [Abstract][Full Text] [Related]
10. Novel approaches for the delivery of therapeutics in ischemic stroke.
Nozohouri S; Sifat AE; Vaidya B; Abbruscato TJ
Drug Discov Today; 2020 Mar; 25(3):535-551. PubMed ID: 31978522
[TBL] [Abstract][Full Text] [Related]
11. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.
Liu XF; Fawcett JR; Thorne RG; DeFor TA; Frey WH
J Neurol Sci; 2001 Jun; 187(1-2):91-7. PubMed ID: 11440750
[TBL] [Abstract][Full Text] [Related]
12. Sustained levels of progesterone prior to the onset of cerebral ischemia are not beneficial to female mice.
Coomber B; Gibson CL
Brain Res; 2010 Nov; 1361():124-32. PubMed ID: 20850417
[TBL] [Abstract][Full Text] [Related]
13. Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.
Hanson LR; Roeytenberg A; Martinez PM; Coppes VG; Sweet DC; Rao RJ; Marti DL; Hoekman JD; Matthews RB; Frey WH; Panter SS
J Pharmacol Exp Ther; 2009 Sep; 330(3):679-86. PubMed ID: 19509317
[TBL] [Abstract][Full Text] [Related]
14. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation.
Fletcher L; Kohli S; Sprague SM; Scranton RA; Lipton SA; Parra A; Jimenez DF; Digicaylioglu M
J Neurosurg; 2009 Jul; 111(1):164-70. PubMed ID: 19284235
[TBL] [Abstract][Full Text] [Related]
15. Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat.
Smith SE; Hodges H; Sowinski P; Man CM; Leach MJ; Sinden JD; Gray JA; Meldrum BS
Neuroscience; 1997 Apr; 77(4):1123-35. PubMed ID: 9130792
[TBL] [Abstract][Full Text] [Related]
16. Cerebroprotection by progesterone following ischemic stroke: Multiple effects and role of the neural progesterone receptors.
Zhu X; Fréchou M; Schumacher M; Guennoun R
J Steroid Biochem Mol Biol; 2019 Jan; 185():90-102. PubMed ID: 30031789
[TBL] [Abstract][Full Text] [Related]
17. Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke.
Jin W; Wu Y; Chen N; Wang Q; Wang Y; Li Y; Li S; Han X; Yang E; Tong F; Wu J; Yuan X; Kang C
Theranostics; 2021; 11(17):8197-8217. PubMed ID: 34373737
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Delivery of Granulocyte Colony-Stimulating Factor Enhances Its Neuroprotective Effects Against Ischemic Brain Injury in Rats.
Sun BL; He MQ; Han XY; Sun JY; Yang MF; Yuan H; Fan CD; Zhang S; Mao LL; Li DW; Zhang ZY; Zheng CB; Yang XY; Li YV; Stetler RA; Chen J; Zhang F
Mol Neurobiol; 2016 Jan; 53(1):320-330. PubMed ID: 25432887
[TBL] [Abstract][Full Text] [Related]
19. Intranasal ginsenoside Rb1 targets the brain and ameliorates cerebral ischemia/reperfusion injury in rats.
Lu T; Jiang Y; Zhou Z; Yue X; Wei N; Chen Z; Ma M; Xu G; Liu X
Biol Pharm Bull; 2011; 34(8):1319-24. PubMed ID: 21804225
[TBL] [Abstract][Full Text] [Related]
20. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
